TW206218B - - Google Patents

Download PDF

Info

Publication number
TW206218B
TW206218B TW080105058A TW80105058A TW206218B TW 206218 B TW206218 B TW 206218B TW 080105058 A TW080105058 A TW 080105058A TW 80105058 A TW80105058 A TW 80105058A TW 206218 B TW206218 B TW 206218B
Authority
TW
Taiwan
Prior art keywords
formula
alkyl
patent application
compound
ministry
Prior art date
Application number
TW080105058A
Other languages
English (en)
Chinese (zh)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of TW206218B publication Critical patent/TW206218B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
TW080105058A 1990-11-24 1991-06-29 TW206218B (OSRAM)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4037437A DE4037437A1 (de) 1990-11-24 1990-11-24 Aminodiol-derivate

Publications (1)

Publication Number Publication Date
TW206218B true TW206218B (OSRAM) 1993-05-21

Family

ID=6418858

Family Applications (1)

Application Number Title Priority Date Filing Date
TW080105058A TW206218B (OSRAM) 1990-11-24 1991-06-29

Country Status (18)

Country Link
EP (1) EP0487980A1 (OSRAM)
JP (1) JPH04266877A (OSRAM)
KR (1) KR920009806A (OSRAM)
CN (1) CN1061778A (OSRAM)
AU (1) AU8808691A (OSRAM)
CA (1) CA2056063A1 (OSRAM)
CS (1) CS354591A3 (OSRAM)
DE (1) DE4037437A1 (OSRAM)
FI (1) FI915495L (OSRAM)
HU (1) HU208964B (OSRAM)
IE (1) IE914081A1 (OSRAM)
MX (1) MX9102186A (OSRAM)
NO (1) NO914584L (OSRAM)
NZ (1) NZ240693A (OSRAM)
PL (1) PL292498A1 (OSRAM)
PT (1) PT99585A (OSRAM)
TW (1) TW206218B (OSRAM)
ZA (1) ZA919245B (OSRAM)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5888992A (en) * 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
US6071895A (en) * 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
BR9306058A (pt) * 1992-03-11 1997-11-18 Narhex Ltd Derivados de amina de hidrocarbonetos oxo- e hidroxi- substituidos
MXPA93002392A (es) 1992-03-11 2005-02-04 Narhex Ltd Derivados amino de hidrocarburos-oxo e hidroxi-substituidos.
US5691368A (en) * 1995-01-11 1997-11-25 Hoechst Marion Roussel, Inc. Substituted oxazolidine calpain and/or cathepsin B inhibitors
KR100709257B1 (ko) * 2005-08-30 2007-04-19 삼성에스디아이 주식회사 연료 공급장치 및 이를 포함하는 연료 전지 시스템
JP2013510145A (ja) * 2009-11-09 2013-03-21 メディヴィル・アクチエボラーグ 1,3−オキサゾリジン化合物およびレニン阻害剤としてのそれらの使用方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0397779A1 (en) * 1988-02-01 1990-11-22 The Upjohn Company Renin inhibiting peptides with polar end groups

Also Published As

Publication number Publication date
PL292498A1 (en) 1992-11-16
NO914584D0 (no) 1991-11-22
NZ240693A (en) 1993-07-27
DE4037437A1 (de) 1992-05-27
FI915495A0 (fi) 1991-11-21
NO914584L (no) 1992-05-25
HUT63621A (en) 1993-09-28
FI915495A7 (fi) 1992-05-25
CA2056063A1 (en) 1992-05-25
HU913654D0 (en) 1992-02-28
HU208964B (en) 1994-02-28
JPH04266877A (ja) 1992-09-22
PT99585A (pt) 1992-10-30
EP0487980A1 (de) 1992-06-03
CS354591A3 (en) 1992-06-17
FI915495L (fi) 1992-05-25
ZA919245B (en) 1992-07-29
KR920009806A (ko) 1992-06-25
IE914081A1 (en) 1992-06-03
CN1061778A (zh) 1992-06-10
MX9102186A (es) 1992-07-08
AU8808691A (en) 1992-05-28

Similar Documents

Publication Publication Date Title
TWI374130B (OSRAM)
Campbell et al. 257. Geometrical isomerism of azo-compounds
TW206218B (OSRAM)
JP4000194B2 (ja) 高純度置換ベンゾ[e]インドールおよびそのアルカリ塩の製造方法
JP6851149B2 (ja) ピペリジン化合物の製造方法
JP3812953B2 (ja) 新規包接化合物及びその製造方法
TW203050B (OSRAM)
WO1999021848A2 (en) Novel 1-(n'-(arylalkylaminoalkyl))aminoisoindoles; a new class of dopamine receptor subtype specific ligands
ES431312A1 (es) Procedimiento de preparacion de nuevos derivados de la fe- nil propenilamina.
Bergstrom et al. The Preparation and Properties of Some 4-Substituted Isoquinolines1
JPS6019748B2 (ja) イソインドリン誘導体の製法
JPS6224428B2 (OSRAM)
US2833776A (en) Aryl-substituted psperidylpropanols
US3280196A (en) Benzhydryl-dihaloalkane ethers
CN108069839A (zh) 利用二溴海因将烯烃转化为alpha-溴代酮的方法
Kaplan et al. Condensation Reactions of Cinchoninaldehyde and Quinaldaldehyde1
Olin et al. Synthesis of 4-PHENYLTHIAZOLE-2-METHANOL and Some of its Derivatives. VIII
US2580475A (en) Imidazolinylalkyl ethers of pyridylcarbinols
US2800485A (en) Method of making mono-
JPS5846514B2 (ja) 3−フエニルインド−ル誘導体の製造法
CN108440291A (zh) 一种可见光催化的1,3-二羰基类化合物脱氢自偶联的方法
US2662891A (en) P-chlorophenyl(2-pyridyl) (beta-dimethylaminoethoxy) methane
Perrine 9-Vinylacridine: preparation and some reactions of it and related substances of possible application in the synthesis of acridine amino alcohols
CA2818438A1 (en) Processes for the preparation of enamines
Harris et al. Quaternary ammonium salts as germicides. V. Quaternary ammonium salts derived from substituted piperidines